These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34056358)
21. Structural basis of the TAM domain of BAZ2A in binding to DNA or RNA independent of methylation status. Chen S; Zhou M; Dong A; Loppnau P; Wang M; Min J; Liu K J Biol Chem; 2021 Dec; 297(6):101351. PubMed ID: 34715126 [TBL] [Abstract][Full Text] [Related]
22. A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations. Su J; Liu X; Zhang S; Yan F; Zhang Q; Chen J Chem Biol Drug Des; 2018 Mar; 91(3):828-840. PubMed ID: 29139214 [TBL] [Abstract][Full Text] [Related]
23. Insights into interaction mechanism of inhibitors E3T, E3H and E3B with CREB binding protein by using molecular dynamics simulations and MM-GBSA calculations. Wu SL; Zhao J; Sun HB; Li HY; Yin YY; Zhang LL SAR QSAR Environ Res; 2021 Mar; 32(3):221-246. PubMed ID: 33661069 [TBL] [Abstract][Full Text] [Related]
24. Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain. Ferguson FM; Fedorov O; Chaikuad A; Philpott M; Muniz JR; Felletar I; von Delft F; Heightman T; Knapp S; Abell C; Ciulli A J Med Chem; 2013 Dec; 56(24):10183-7. PubMed ID: 24304323 [TBL] [Abstract][Full Text] [Related]
25. Binding mechanism of inhibitors to p38α MAP kinase deciphered by using multiple replica Gaussian accelerated molecular dynamics and calculations of binding free energies. Chen J; Wang W; Sun H; Pang L; Bao H Comput Biol Med; 2021 Jul; 134():104485. PubMed ID: 33993013 [TBL] [Abstract][Full Text] [Related]
26. Decoding drug resistant mechanism of V32I, I50V and I84V mutations of HIV-1 protease on amprenavir binding by using molecular dynamics simulations and MM-GBSA calculations. Yu YX; Wang W; Sun HB; Zhang LL; Wang LF; Yin YY SAR QSAR Environ Res; 2022 Oct; 33(10):805-831. PubMed ID: 36322686 [TBL] [Abstract][Full Text] [Related]
27. Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5. Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142969 [TBL] [Abstract][Full Text] [Related]
28. Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching. Philpott M; Rogers CM; Yapp C; Wells C; Lambert JP; Strain-Damerell C; Burgess-Brown NA; Gingras AC; Knapp S; Müller S Epigenetics Chromatin; 2014; 7():14. PubMed ID: 25097667 [TBL] [Abstract][Full Text] [Related]
29. Probing molecular mechanism of inhibitor bindings to bromodomain-containing protein 4 based on molecular dynamics simulations and principal component analysis. Wu SL; Wang LF; Sun HB; Wang W; Yu YX SAR QSAR Environ Res; 2020 Jul; 31(7):547-570. PubMed ID: 32657160 [TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism concerning conformational changes of CDK2 mediated by binding of inhibitors using molecular dynamics simulations and principal component analysis. Liang SS; Liu XG; Cui YX; Zhang SL; Zhang QG; Chen JZ SAR QSAR Environ Res; 2021 Jun; ():1-22. PubMed ID: 34130570 [TBL] [Abstract][Full Text] [Related]
32. Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations. Wang L; Wang Y; Zhao J; Yu Y; Kang N; Yang Z RSC Adv; 2022 Jun; 12(26):16663-16676. PubMed ID: 35754900 [TBL] [Abstract][Full Text] [Related]
33. Insights into the selectivity of a brain-penetrant CDK4/6 vs CDK1/2 inhibitor for glioblastoma used in multiple replica molecular dynamics simulations. Sun J; Liang S; Liu X; Zhang S; Li M; Zhang Q; Chen J J Biomol Struct Dyn; 2023 Dec; ():1-20. PubMed ID: 38112295 [TBL] [Abstract][Full Text] [Related]
34. Binding Mechanism of Inhibitors to Heat Shock Protein 90 Investigated by Multiple Independent Molecular Dynamics Simulations and Prediction of Binding Free Energy. Yang F; Wang Y; Yan D; Liu Z; Wei B; Chen J; He W Molecules; 2023 Jun; 28(12):. PubMed ID: 37375347 [TBL] [Abstract][Full Text] [Related]
35. Protein dynamics and structural waters in bromodomains. Zhang X; Chen K; Wu YD; Wiest O PLoS One; 2017; 12(10):e0186570. PubMed ID: 29077715 [TBL] [Abstract][Full Text] [Related]
36. Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. Chen J; Pang L; Wang W; Wang L; Zhang JZH; Zhu T J Biomol Struct Dyn; 2020 Mar; 38(4):985-996. PubMed ID: 30843759 [TBL] [Abstract][Full Text] [Related]
37. Ligand selectivity of estrogen receptors by a molecular dynamics study. Hu G; Wang J Eur J Med Chem; 2014 Mar; 74():726-35. PubMed ID: 23694906 [TBL] [Abstract][Full Text] [Related]
38. Structured water molecules in the binding site of bromodomains can be displaced by cosolvent. Huang D; Rossini E; Steiner S; Caflisch A ChemMedChem; 2014 Mar; 9(3):573-9. PubMed ID: 23804246 [TBL] [Abstract][Full Text] [Related]
39. A histone-mimicking interdomain linker in a multidomain protein modulates multivalent histone binding. Kostrhon S; Kontaxis G; Kaufmann T; Schirghuber E; Kubicek S; Konrat R; Slade D J Biol Chem; 2017 Oct; 292(43):17643-17657. PubMed ID: 28864776 [TBL] [Abstract][Full Text] [Related]
40. In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4. Rodríguez Y; Gerona-Navarro G; Osman R; Zhou MM Proteins; 2020 Mar; 88(3):414-430. PubMed ID: 31587361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]